- Home
- About Us
- Programs
- After Hours Initiative
- Chronic Disease Prevention and Management
- Coordinated Veterans’ Care
- eHealth and Information Management
- Effective Resource Management
- Indigenous Health
- Immunisation
- Lifescripts
- Mind the Gap
- National Primary Mental Health Program
- Nursing in General Practice
- Quality Use of Medicines (QUM)
- Rural Palliative Care Project
- Policy
- Media
- Transition
Programs
Vaccine knocks out Serotype B Meningococcus
Vaccine knocks out Serotype B Meningococcus
A study of 1,631 adolescents between the ages of 11 and 17 years shows that an investigational vaccine against Neisseria meningitidis, or serogroup B meningococcus, provides near-universal protection. The level of antibody titers rose to almost 100 percent with a booster dose. Published in The Lancet, the study indicates that two doses of 4CMenB may be ideal, with the second dose given one to six months after the first.
Click here for more information.
Contact:
Phone:
Copyright © 2010 Australian General Practice Network.
Address: Ground Floor, Minter Ellison Building, 25 National Circuit, Forrest ACT 2601
Postal Address: PO Box 4308, Manuka ACT 2603
Phone: 02 6228 0800 | Fax: 02 6228 0899 | Email: agpnreception@agpn.com.au
ABN: 95 082 812 146